Literature DB >> 110064

Accuracy of ultrasonography in diagnosis of hepatocellular disease.

B B Gosink, S K Lemon, W Scheible, G R Leopold.   

Abstract

Retrospective evaluations were made of abdominal echograms in 61 patients who underwent liver biopsy within 3 weeks after ultrasound study. Without knowledge of clinical or biopsy data, determinations were made by two independent observers of: (1) liver size, (2) beam penetration, (3) echogenicity, (4) vascularity, (5) ancillary abnormality, and (6) diagnostic impression. Using these parameters, the presence of generalized parenchymal disease was identified in 81% of reviews of patients with cirrhosis. Thus, in patients with known cirrhosis, there was a 19% false negative rate. In normal patients, 76% were correctly called normal by the reviewers. However, in 24% generalized parenchymal disease was suggested (24% false positive). Patients with fatty liver could not be reliably distinguished from patients with cirrhosis, nor could patients with hepatitis be easily separated from those with normal livers. In all of these determinations, the combination of several features provided more diagnostic accuracy than any single echographic finding.

Entities:  

Mesh:

Year:  1979        PMID: 110064     DOI: 10.2214/ajr.133.1.19

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  15 in total

Review 1.  Accuracy of ultrasound to identify chronic liver disease.

Authors:  Richard Allan; Kerry Thoirs; Maureen Phillips
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

2.  Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis.

Authors:  Ruben Hernaez; Mariana Lazo; Susanne Bonekamp; Ihab Kamel; Frederick L Brancati; Eliseo Guallar; Jeanne M Clark
Journal:  Hepatology       Date:  2011-09-02       Impact factor: 17.425

3.  Prospective evaluation of the diagnostic accuracy of liver ultrasonography.

Authors:  J C Debongnie; C Pauls; M Fievez; E Wibin
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

4.  Lymph node enlargement as a sign of acute hepatitis A in children.

Authors:  V Toppet; H Souayah; O Delplace; S Alard; J Moreau; J Levy; M Spehl
Journal:  Pediatr Radiol       Date:  1990

5.  Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C.

Authors:  A K P Lim; S D Taylor-Robinson; N Patel; R J Eckersley; R D Goldin; G Hamilton; G R Foster; H C Thomas; D O Cosgrove; M J K Blomley
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

6.  Noninvasive evaluation of hepatic fibrosis using frequency demodulation of ultrasound signals.

Authors:  J C Hoefs; D Aufrichtig; S Lottenberg; G C Kanel; B S Donner; L A Ferrari; S Leeman; R M Friedenberg
Journal:  Dig Dis Sci       Date:  1986-10       Impact factor: 3.199

7.  Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study.

Authors:  M J K Blomley; A K P Lim; C J Harvey; N Patel; R J Eckersley; R Basilico; R Heckemann; A Urbank; D O Cosgrove; S D Taylor-Robinson
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

8.  Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques.

Authors:  G Celle; V Savarino; A Picciotto; M R Magnolia; P Scalabrini; M Dodero
Journal:  Dig Dis Sci       Date:  1988-04       Impact factor: 3.199

9.  Noninvasive imaging of unusual regenerating nodules in the cirrhotic liver.

Authors:  F C Laing; R B Jeffrey; M P Federle; J P Cello
Journal:  Gastrointest Radiol       Date:  1982

10.  Discordance between conventional ultrasonography and ElastPQ for assessing hepatic fibrosis in chronic hepatitis B: frequency and independent factors.

Authors:  Mi Sung Kim; Byung Ik Kim; Heon-Ju Kwon; Hae Won Park; Hee-Jin Park; Ki Bae Bang; Hyun Pyo Hong; Myung Ho Rho
Journal:  J Med Ultrason (2001)       Date:  2015-11-05       Impact factor: 1.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.